Bayesian adaptive dose-escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy. (2017)

First Author: Yeung WY
Attributed to:  MRC North West Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/pst.1818

PubMed Identifier: 28691311

Publication URI: http://europepmc.org/abstract/MED/28691311

Type: Journal Article/Review

Volume: 16

Parent Publication: Pharmaceutical statistics

Issue: 6

ISSN: 1539-1604